Pfizer drug sales fall, lower-margin units shine

from a weaker dollar that boosted the value of sales abroad, new products obtained by the purchase of King Pharmaceuticals and a sharply lower tax rate. Revenue of $16.5 billion was a bit lower than a year earlier and trailed Wall Street expectations of...